# Teligent Pharma, Inc. – FDA Inspection, May 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/teligent-pharma-inc/67eb4a19-49ae-4c3f-97a1-43cc71400846
Source feed: FDA_Inspections

> FDA inspection 1090090 of Teligent Pharma, Inc., May 20, 2019. 10 citations under 21 CFR parts 211 and 314. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090090
- Company Name: Teligent Pharma, Inc.
- Inspection Date: 2019-05-20
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 10

## Related Documents

- [FDA Inspection 1150271 - 2021-08-31](https://www.keypedia.com/records/fda_inspections/teligent-pharma-inc/eb729f01-1b0b-4787-bbb2-2ec0cd04754f)
- [FDA Inspection 1032023 - 2017-10-19](https://www.keypedia.com/records/fda_inspections/teligent-pharma-inc/849e2f32-f078-471b-9a6e-44718b9300d3)
- FDA Inspection 956413 - 2016-01-22
- FDA Inspection 859472 - 2013-12-19
- [FDA Inspection 765396 - 2012-02-02](https://www.keypedia.com/records/fda_inspections/teligent-pharma-inc/ca87a5c5-e316-42cc-9696-c8abe240102c)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-m-espinal/f4494790-6a37-4998-853c-f859a0eb3330)

Company: https://www.keypedia.com/companies/teligent-pharma-inc/1605ff29-0e1f-49ed-9bba-a5f897375249

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248